This page covers gene editing, drug development, genomics and the intersection of biology and technology. Reporting follows clinical trials, regulatory filings, corporate acquisitions and the results of scientific studies.
Roberts, formerly a partner at Venable, joins Mintz's Intellectual Property Practice in New York to handle life sciences patent disputes.
Live Poll
Do you trust large law firms to serve ordinary people fairly?
October 27, 2026
Rumi Therapeutics Licenses PDE2 Inhibitor for Fragile XThe company has secured rights to the investigational drug candidate RTX-7340 to target Fragile X syndrome.
October 14, 2026
Neion Bio and Barnwell Bio Formed PartnershipThe two New York City biotechnology firms have joined forces to enhance biosecurity in avian drug manufacturing.
October 13, 2026
Wave Life Sciences to Join NYC Healthcare PanelCEO Paul Bolno will speak at Chardan's 10th Annual Healthcare Conference on October 20, 2026.
October 13, 2026
NCI Awarded Envisagenics $2 Million Biotech GrantThe National Cancer Institute issued the grant to support Envisagenics in developing its new machine learning algorithm.
October 10, 2026
Nuvectis Pharma Will Join Maxim Growth SummitThe biopharmaceutical firm will discuss its clinical-stage pipeline at the upcoming New York City industry event.
October 9, 2026
Filana Therapeutics Will Attend 2026 Maxim Growth SummitThe biotech firm will join investor meetings at the Hard Rock Hotel NYC from October 12-14, 2026.
October 6, 2026
Seth Flaum Joined McDermott Will & EmeryThe health and life sciences attorney has joined the firm's New York practice group.
October 5, 2026
4D Molecular Therapeutics Will Host Investor Day October 21The biotech firm will hold a presentation in New York City regarding its pipeline and clinical progress.
September 30, 2026
Sol-Gel Technologies Will Host Investor Event in OctoberThe dermatology company will present updates on its SGT-610 drug candidate during an event in New York.
September 24, 2026
Researchers Mapped PIP2 Binding Site on Retinal ChannelsA study published on September 3, 2026, revealed how PIP2 molecules regulate light sensitivity in human retinal rod cells.
This section follows clinical trial outcomes, new therapy approvals, genomics research and market activity in the sector. It reaches across the city and into the surrounding metropolitan areas where research and commercial operations intersect. Innovation in this field is often tied to the university labs and private facilities that anchor development. Corporate investments and the pace of regulatory reviews are the two factors that drive the frequency of coverage.
